Clinical trial registry record

Appropriate Prescribing for Older Adults With Multimorbidity (Pro-M)

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 9, 2024.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05756478
Last registry update
February 9, 2024
Status
Completed
Phase
Phase not reported
Sponsor
Geriatric Education and Research Institute
Enrollment
36
Countries
Singapore
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NA · SINGLE GROUP · HEALTH SERVICES RESEARCH · NONE
Evidence population
Human clinical study registration
Participants
36
Population
ALL · 21 Years to 99 Years
Duration
2023-02-01 to 2023-10-16
Intervention
Medication review
Comparator
Not reported
Outcomes measured
Patients' attitudes towards acceptance of the intervention (Penetration/Reach) — A single-time-point survey to be admin…; Implementers' attitudes towards the appropriateness of the intervention — 3-month Evaluation period: A single-time-poin…; Implementers' attitudes towards the acceptability of the intervention — 3-month Evaluation period: A single-time-point…; Implementers' attitudes towards the feasibility of the intervention. — 3-month Evaluation period: A single-time-point s…; Implementers' attitudes towards the sustainability of the intervention. — 3-month Evaluation period: A single-time-poin…; Implementers' views on the fidelity of the intervention. — :3-month Evaluation period: A single-time-point survey to be…; Recruitment rate — 6 months during implementation period; Effectiveness of the intervention: Percentage of patients with at least one PIM before and after intervention. — 6 mont…; Effectiveness of the intervention: Percentage of patients with other medication issues identified before and after inte…; Manpower cost to conduct medication review — 6 months during implementation period; Cost of PIM and other medications with issues identified before and after medication review. — 6 months during implemen…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Multimorbidity · 100%Title contains controlled term: multimorbidity. Abstract contains controlled term: multimorbidity. Source terminology contains: multimorbidity. Title supplies longevity context: older adult. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.